March 29, 2024 News by Andrea Lobo, PhD BCG vaccine to prevent tuberculosis not linked to MS risk: Study Getting the Bacillus Calmette-Guerin (BCG) vaccine to protect against tuberculosis (TB) or having latent (inactive) TB in young adulthood aren’t linked to the risk of developing multiple sclerosis (MS), a Norwegian study found. The study, āBCG vaccination and multiple sclerosis risk: A Norwegian cohort study,ā was published in…
September 26, 2023 News by Margarida Maia, PhD COVID-19 vaccines safe, do not worsen MS symptoms: Study Certain COVID-19 vaccines do not appear to worsen the symptoms of multiple sclerosis (MS), and may provide protection for at least six months after a booster dose, according to a study in Spain. The study specifically examined mRNA vaccines, or those that use a piece of RNA to teach…
May 16, 2022 News by Marisa Wexler, MS With Rituximab, B-cell Counts Predict COVID-19 Vaccine Response Among multiple sclerosis (MS) patients on rituximab, higher B-cell counts are predictive of a better antibody-based response to a vaccine for COVID-19, according to a new Swedish study. “In our study, the B-cell level in patients given Rituximab was the only factor that influenced the ability to form antibodies…
September 8, 2021 News by Marisa Wexler, MS Risk of MS Relapse Not Increased by COVID-19 Vaccine, Study Finds Getting the Pfizer-BioNTech vaccine for COVID-19 does not increase the risk of multiple sclerosis (MS) relapses in the two months following vaccination, according to a new study. The results support recommending COVID-19 vaccines for people with MS, its researchers said. “The incidence of relapses in the 2āmonths before and…
May 13, 2021 News by Patricia Inacio, PhD Conversational Bot to Promote COVID-19 Vaccination Among Patients A conversational bot is being developed at the University of Illinois at Urbana-Champaign (UIUC) to promote COVID-19 vaccinations among people with multiple sclerosis (MS) who are hesitant to take the vaccine. The project is meant to provide accessible digital health information about the vaccines to more vulnerable populations…
August 5, 2019 News by Ana Pena PhD Vaccines Pose No Risk of Developing MS, Large Population Study in Germany Reports Vaccines are not a risk factor for multiple sclerosis (MS), a large data analysis spanning more than 12,250 MS patients in Germany shows. Fewer vaccinations were given to people who ā five years later ā would be diagnosed with MS, compared to those who would be diagnosed with…
May 2, 2019 Columns by Jennifer (Jenn) Powell With an Autoimmune Disease, Fear of a Measles Outbreak Is Real Few things scare me. I mean, truly frighten me to my core. While I flee from bees and scream at spiders, I have been both stung and bitten. Scary movies, no matter how asinine, freak me out. Being alone in the dark invokes vivid imagination. Jason, Freddy, and Michael Myers.
May 31, 2018 News by Diogo Pinto HPV Vaccine Not Seen to Raise Risk of Autoimmune Disease in Canadian Study Girls given the quadrivalent human papillomavirus (HPV4) vaccination, commercialized asĀ Gardasil, showed no increased risk of developing autoimmune diseases like multiple sclerosis (MS), according to a new Canadian study. The time since vaccination and the number of vaccine doses given also did not correlate with diagnoses of such disorders, supporting…
June 6, 2017 News by Patricia Silva, PhD Ongoing Ocrevus Trials Seek More Knowledge of Treatment Effects and MS Patients’ Benefits Ocrevus (ocrelizumab), a recently approvedĀ therapy for relapsing and primary progressive multiple sclerosis (MS),Ā is now on the U.S. market, but research intoĀ itsĀ use is far from over. Several clinical trials, sponsored by Ocrevus’ developer Genentech or its parent company Roche, are looking at various aspectsĀ of the treatment. Multiple Sclerosis…
September 25, 2015 News by Patricia Silva, PhD Possible JC Virus Vaccination Offers Important Implications for MS Treatment Two studies recently published in the journal Science Translational Medicine, revealed a possible new vaccine treatment for JC virus with important implications for multiple sclerosis (MS) treatment. The studies are entitled āJC polyomavirus mutants escape antibody-mediated neutralizationā and āBroadly neutralizing human…